分层分析确定HIF-2α作为高度免疫透的黑色素瘤的治疗点
Amy Y Huang1,2,3,4,5, Kelly P Burke1,2,3,4, Ryan Porter3,4
1Dana-Farber Cancer Institute, Boston, MA, USA.
bioRxiv : the preprint server for biology
|November 18, 2024
概括
高免疫透率预测了对转移性黑色素瘤组合免疫疗法的反应. 缺氧标志表明对抗PD-1疗法没有反应,特别是在免疫强度高的瘤中,这表明新的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 免疫检查点阻塞 (ICB) 改变了转移性黑色素瘤的治疗方法.
- 鉴定ICB反应的强大的生物标志物仍然具有挑战性,因为治疗和患者的变化.
研究的目的:
- 在转移性黑色素瘤中识别免疫检查点阻塞反应的生物标志物.
- 调查缺氧和特定分子点在治疗耐药性的作用.
主要方法:
- 用抗PD-1,抗CTLA-4或组合ICB治疗的八个患者队伍的标准化元分析.
- 在治疗前的瘤中进行RNA测序和单细胞RNA测序 (scRNA-seq).
- 临床前模型测试HIF-2α抑制与抗PD-1结合使用.
主要成果:
- 高免疫透预测对组合ICB的反应,但不是单独抗PD-1.
- 低氧特征与高免疫性黑色素瘤中对抗PD-1的不响应相关.
- 在免疫透黑色素瘤模型中,HIF-2α抑制与抗PD-1结合改善瘤控制.
结论:
- 通过免疫透和分子特征的分层细化完善了对ICB反应的理解.
- 缺氧信号和HIF-2α代表了黑色素瘤组合策略的潜在治疗点.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480